Docket Room.
SB 124·MD·senate

Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling

WithdrawnFiled Oct 28, 2025
Sponsor: Benson
Latest Action

Withdrawn by Sponsor (Senate)

Feb 9, 2026

Email me when SB 124 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 124. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would prohibit the sale of any product that modifies gene structure or function unless it is labeled prominently with the phrase “gene structure‑ or function‑modifying product” and a list of all reasonably possible risks. It targets manufacturers, distributors, and retailers of such biotech products, imposing criminal and civil penalties for violations. The measure received an unfavorable report in the Senate and was subsequently withdrawn.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 124

3 free questions a day, no account

History

  1. Withdrawn by Sponsor
  2. First Reading Finance
  3. Pre-filed

Sponsors

  • Benson · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 124 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 124 free

Or ask your AI assistant about SB 124 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice